US 9156837
Heterocyclic compound
granted A61PA61P1/04A61P1/16
Quick answer
US patent 9156837 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/00